Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas Review

   


Authors: Hu, B.; Korsos, V.; Palomba, M. L.
Review Title: Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomas
Abstract: Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary approach in the treatment of lymphoma. This review article provides an overview of the four FDA-approved CAR T-cell products for aggressive B-cell lymphoma, including diffuse large B-cell lymphoma and mantle cell lymphoma, highlighting their efficacy and toxicity as well as discussing future directions. Copyright © 2024 Hu, Korsos and Palomba.
Keywords: review; follow up; mantle cell lymphoma; hematopoietic stem cell transplantation; cost effectiveness analysis; leukapheresis; cytokine release syndrome; diffuse large b cell lymphoma; mantle cell lymphoma (mcl); human; chimeric antigen receptor t-cell immunotherapy; axicabtagene ciloleucel; lisocabtagene maraleucel; high grade b cell lymphoma; chimeric antigen receptor t cell therapy (car t cell therapy); diffuse large b cell lymphoma (dlbcl); relapsed and refractory lymphoma; aggressive b cell non hodgkin lymphoma; bridging therapy
Journal Title: Frontiers in Oncology
Volume: 14
ISSN: 2234-943X
Publisher: Frontiers Media S.A.  
Date Published: 2024-06-30
Start Page: 1394057
Language: English
DOI: 10.3389/fonc.2024.1394057
PROVIDER: scopus
PMCID: PMC11246842
PUBMED: 39011476
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198513204&doi=10.3389%2ffonc.2024.1394057&partnerID=40&md5=74a4642fb460919f0beca7c04cb67285
Notes: Review -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba
  2. Victoria Korsos
    1 Korsos
Related MSK Work